Worlds apart? A comparison of the new product development strategies of biopharmaceutical firms in Europe and the USA. Industry and Innovation.
Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how the...
Saved in:
Main Authors: | Tianjiao Xia, Stephen Roper |
---|---|
Format: | Default Article |
Published: |
2009
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/14653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Absorptive capacity and openness of small biopharmaceutical firms - a European Union-United States comparison
by: Tianjiao Xia
Published: (2013) -
From capability to connectivity - absorptive capacity and exploratory alliances in biopharmaceutical firms: a US-Europe comparison
by: Tianjiao Xia, et al.
Published: (2008) -
Beyond the transnational: exploring organisational complexity and innovation in biopharmaceutical firms
by: Samantha Macro
Published: (2021) -
A Quality by Digital Design framework for pharmaceuticals and biopharmaceuticals
by: Brahim Benyahia
Published: (2022) - European journal of pharmaceutics and biopharmaceutics